The Elderly Project by the Fondazione Italiana Linfomi: A Prospective Comprehensive Geriatric Assessment (Cga) of 1353 Elderly Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.58_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma: A Phase II Multicenter Study of the Fondazione Italiana Linfomi

Haematologica
Hematology
2018English

Pet-Driven Radiotherapy in Patients With Low Risk Diffuse Large B-Cell Lymphoma (Dlbcl): The Dlcl10 Multicenter Phase 2 Trial by Fondazione Italiana Linfomi (Fil)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Comprehensive Geriatric Assessment Is an Essential Tool to Support Treatment Decisions in Elderly Patients With Diffuse Large B-Cell Lymphoma: A Prospective Multicenter Evaluation in 173 Patients by the Lymphoma Italian Foundation (FIL)

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2014English

Impact of Comorbidities on Outcomes of Elderly Patients With Diffuse Large B-Cell Lymphoma

American Journal of Hematology
Hematology
2017English

Efficacy and Tolerability of Anthracycline-Based Therapy in Elderly Patients With Diffuse Large B-Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Comprehensive Geriatric Assessment and Treatment of Elderly Diabetic Patients.

Japanese Journal of Geriatrics
GerontologyGeriatrics
2002English

Non-Anthracycline Chemotherapy Associated With a Poor Outcome in Elderly Egyptian Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

Journal of Cancer Metastasis and Treatment
2015English

O3-3-2An Effect of Comprehensive Geriatric Assessment in Elderly Patients With Non-Hodgkin Lymphoma Treated With Chemotherapy

Annals of Oncology
MedicineOncologyHematology
2018English

Treatment of Diffuse Large B-Cell Lymphoma in Elderly Patients; Replacing Doxorubicin With Either Epirubicin or Etoposide (VP-16)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy